12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Zealand Pharma preclinical data

In a mouse model of diabetes, once-daily ZP3022 led to a significant increase in beta-cell mass at week 8 vs. both liraglutide- and...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >